News
A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
Get ready for several years of even more record-breaking heat that pushes Earth to more deadly, fiery and uncomfortable ...
Transthyretin amyloidosis (ATTR) is a condition caused by TTR protein misfolding and amyloid deposition, particularly in the ...
Partner presentations reinforce ability of proprietary AzymetricTM platform to develop clinically validated therapeutic antibodies <li ...
Somatic hypermutation (SHM) of immunoglobulin variable (V) regions modulates antibody-antigen affinity is initiated by activation-induced cytidine deaminase (AID) on single-stranded DNA (ssDNA).
The work provides a panoramic view of the research landscape on cuproptosis in cancer, highlighting its potential as a therapeutic target and the need for further ... relevance excluded based on their ...
21d
The Punch on MSNData Fusion as a Strategic Solution to Telecommunication Cybersecurity Threats in NigeriaAbstractThe telecommunication sector in Nigeria has undergone a rapid digital metamorphosis, emerging as catalyst engine of socio-economic dynamism and a target of escalating cybersecurity adversities ...
Barclays lowered the firm’s price target on SiteOne Landscape (SITE) to $106 from $120 and keeps an Underweight rating on the shares as part of a Q1 earnings preview for the homebuilding and ...
Stifel raised the firm’s price target on SiteOne Landscape (SITE) to $145 from $140 and keeps a Hold rating on the shares. Following Q4 earnings, the firm expresses “an increased positive bias ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results